# AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

> **NCT05628636** · PHASE1 · COMPLETED · sponsor: **Cerecin** · enrollment: 18 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** AC-OLE-01-VA

## Key facts

- **NCT ID:** NCT05628636
- **Lead sponsor:** Cerecin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-14
- **Primary completion:** 2022-12-22
- **Final completion:** 2023-04-03
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05628636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05628636, "AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05628636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*